These data suggest that AR signaling activates TOP2A during DNA replication in prostate cancer cells, and SPOP-dependent removal of TOP2A from the TOP2A-DNA cleavage complex is necessary for the completion of DNA replication. This evidence concerns the gene TOP2A and prostate carcinoma.